enVVeno Medical Corporation
NVNO
$10.53
$0.232.23%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -8.28% | -2.43% | 10.96% | 5.73% | -0.63% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.54% | -1.94% | 6.03% | -2.79% | -5.59% |
| Operating Income | 13.54% | 1.94% | -6.03% | 2.79% | 5.59% |
| Income Before Tax | 10.76% | -3.42% | -11.99% | 3.55% | 7.22% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 10.76% | -3.42% | -11.99% | 3.55% | 7.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.76% | -3.42% | -11.99% | 3.55% | 7.22% |
| EBIT | 13.54% | 1.94% | -6.03% | 2.79% | 5.59% |
| EBITDA | 13.43% | 1.71% | -6.36% | 2.61% | 5.52% |
| EPS Basic | 25.66% | 19.04% | 15.56% | 34.25% | 41.15% |
| Normalized Basic EPS | 29.43% | 24.86% | 21.02% | 34.34% | 40.38% |
| EPS Diluted | 25.66% | 19.04% | 15.56% | 34.25% | 41.15% |
| Normalized Diluted EPS | 29.43% | 24.86% | 21.02% | 34.34% | 40.38% |
| Average Basic Shares Outstanding | 20.20% | 27.57% | 31.11% | 39.46% | 50.17% |
| Average Diluted Shares Outstanding | 20.20% | 27.57% | 31.11% | 39.46% | 50.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |